Innovent and Eli Lilly’s trial of TYVYT meets primary endpoint

The ORIENT-12 Phase III trial evaluated TYVYT, Gemzar and platinum chemotherapy combination to treat metastatic squamous non-small cell lung cancer. Credit: Nephron.